<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-ijms-20-05952">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arita</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yoshida</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tjonahen</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Glickman</surname>
    <given-names>J.N.</given-names>
   </name>
   <name>
    <surname>Petasis</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Blumberg</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Serhan</surname>
    <given-names>C.N.</given-names>
   </name>
  </person-group>
  <article-title>Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis</article-title>
  <source>Proc. Natl Acad Sci USA</source>
  <year>2005</year>
  <volume>102</volume>
  <fpage>7671</fpage>
  <lpage>7676</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0409271102</pub-id>
  <pub-id pub-id-type="pmid">15890784</pub-id>
 </element-citation>
</ref>
